Open2.330 | Close- |
Vol / Avg.181.887K / 269.303K | Mkt Cap145.144M |
Day Range2.250 - 2.350 | 52 Wk Range2.320 - 8.780 |
Seer Stock (NASDAQ: SEER) stock price, news, charts, stock research, profile.
Open2.330 | Close- |
Vol / Avg.181.887K / 269.303K | Mkt Cap145.144M |
Day Range2.250 - 2.350 | 52 Wk Range2.320 - 8.780 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 5.070M | 4.008M | -1.062M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-21 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 11.00 | 10.00 |
2023-01-04 | B of A Securities | Derik De Bruin | Downgrades | NeutralUnderperform | Lowers | 9.00 | 6.50 |
2022-11-10 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 14.00 | 11.00 |
2022-08-11 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 19.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SEER | Seer | -3.4% | 145.1M |
HBIO | Harvard Bioscience | 1.71% | 178M |
CDXS | Codexis | -5% | 112.7M |
BLFS | BioLife Solns | -0.08% | 551.9M |
SLGC | SomaLogic | -1.75% | 423.2M |
You can purchase shares of Seer (NASDAQ: SEER) through any online brokerage.
Other companies in Seer’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), SomaLogic (NASDAQ:SLGC) and ChromaDex (NASDAQ:CDXC).
The latest price target for Seer (NASDAQ: SEER) was reported by Morgan Stanley on Tuesday, February 21, 2023. The analyst firm set a price target for 10.00 expecting SEER to rise to within 12 months (a possible 340.53% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Seer (NASDAQ: SEER) is $2.27 last updated Today at September 21, 2023 at 7:35 PM UTC.
There is no dividend information for Seer.
Seer’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Seer.
Seer is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Seer Stock (NASDAQ: SEER) stock price, news, charts, stock research, profile.
Open2.330 | Close- |
Vol / Avg.181.887K / 269.303K | Mkt Cap145.144M |
Day Range2.250 - 2.350 | 52 Wk Range2.320 - 8.780 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 5.070M | 4.008M | -1.062M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-21 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 11.00 | 10.00 |
2023-01-04 | B of A Securities | Derik De Bruin | Downgrades | NeutralUnderperform | Lowers | 9.00 | 6.50 |
2022-11-10 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 14.00 | 11.00 |
2022-08-11 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 19.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SEER | Seer | -3.4% | 145.1M |
HBIO | Harvard Bioscience | 1.71% | 178M |
CDXS | Codexis | -5% | 112.7M |
BLFS | BioLife Solns | -0.08% | 551.9M |
SLGC | SomaLogic | -1.75% | 423.2M |
You can purchase shares of Seer (NASDAQ: SEER) through any online brokerage.
Other companies in Seer’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), SomaLogic (NASDAQ:SLGC) and ChromaDex (NASDAQ:CDXC).
The latest price target for Seer (NASDAQ: SEER) was reported by Morgan Stanley on Tuesday, February 21, 2023. The analyst firm set a price target for 10.00 expecting SEER to rise to within 12 months (a possible 340.53% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Seer (NASDAQ: SEER) is $2.27 last updated Today at September 21, 2023 at 7:35 PM UTC.
There is no dividend information for Seer.
Seer’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Seer.
Seer is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Seer Stock (NASDAQ: SEER) stock price, news, charts, stock research, profile.
Open2.330 | Close- |
Vol / Avg.181.887K / 269.303K | Mkt Cap145.144M |
Day Range2.250 - 2.350 | 52 Wk Range2.320 - 8.780 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 5.070M | 4.008M | -1.062M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-21 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 11.00 | 10.00 |
2023-01-04 | B of A Securities | Derik De Bruin | Downgrades | NeutralUnderperform | Lowers | 9.00 | 6.50 |
2022-11-10 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 14.00 | 11.00 |
2022-08-11 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 19.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SEER | Seer | -3.4% | 145.1M |
HBIO | Harvard Bioscience | 1.71% | 178M |
CDXS | Codexis | -5% | 112.7M |
BLFS | BioLife Solns | -0.08% | 551.9M |
SLGC | SomaLogic | -1.75% | 423.2M |
You can purchase shares of Seer (NASDAQ: SEER) through any online brokerage.
Other companies in Seer’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), SomaLogic (NASDAQ:SLGC) and ChromaDex (NASDAQ:CDXC).
The latest price target for Seer (NASDAQ: SEER) was reported by Morgan Stanley on Tuesday, February 21, 2023. The analyst firm set a price target for 10.00 expecting SEER to rise to within 12 months (a possible 340.53% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Seer (NASDAQ: SEER) is $2.27 last updated Today at September 21, 2023 at 7:35 PM UTC.
There is no dividend information for Seer.
Seer’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Seer.
Seer is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Seer Stock (NASDAQ: SEER) stock price, news, charts, stock research, profile.
Open2.330 | Close- |
Vol / Avg.181.887K / 269.303K | Mkt Cap145.144M |
Day Range2.250 - 2.350 | 52 Wk Range2.320 - 8.780 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 5.070M | 4.008M | -1.062M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-21 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 11.00 | 10.00 |
2023-01-04 | B of A Securities | Derik De Bruin | Downgrades | NeutralUnderperform | Lowers | 9.00 | 6.50 |
2022-11-10 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 14.00 | 11.00 |
2022-08-11 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 19.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SEER | Seer | -3.4% | 145.1M |
HBIO | Harvard Bioscience | 1.71% | 178M |
CDXS | Codexis | -5% | 112.7M |
BLFS | BioLife Solns | -0.08% | 551.9M |
SLGC | SomaLogic | -1.75% | 423.2M |
You can purchase shares of Seer (NASDAQ: SEER) through any online brokerage.
Other companies in Seer’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), SomaLogic (NASDAQ:SLGC) and ChromaDex (NASDAQ:CDXC).
The latest price target for Seer (NASDAQ: SEER) was reported by Morgan Stanley on Tuesday, February 21, 2023. The analyst firm set a price target for 10.00 expecting SEER to rise to within 12 months (a possible 340.53% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Seer (NASDAQ: SEER) is $2.27 last updated Today at September 21, 2023 at 7:35 PM UTC.
There is no dividend information for Seer.
Seer’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Seer.
Seer is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Seer Stock (NASDAQ: SEER) stock price, news, charts, stock research, profile.
Open2.330 | Close- |
Vol / Avg.181.887K / 269.303K | Mkt Cap145.144M |
Day Range2.250 - 2.350 | 52 Wk Range2.320 - 8.780 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 5.070M | 4.008M | -1.062M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-21 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 11.00 | 10.00 |
2023-01-04 | B of A Securities | Derik De Bruin | Downgrades | NeutralUnderperform | Lowers | 9.00 | 6.50 |
2022-11-10 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 14.00 | 11.00 |
2022-08-11 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 19.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SEER | Seer | -3.4% | 145.1M |
HBIO | Harvard Bioscience | 1.71% | 178M |
CDXS | Codexis | -5% | 112.7M |
BLFS | BioLife Solns | -0.08% | 551.9M |
SLGC | SomaLogic | -1.75% | 423.2M |
You can purchase shares of Seer (NASDAQ: SEER) through any online brokerage.
Other companies in Seer’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), SomaLogic (NASDAQ:SLGC) and ChromaDex (NASDAQ:CDXC).
The latest price target for Seer (NASDAQ: SEER) was reported by Morgan Stanley on Tuesday, February 21, 2023. The analyst firm set a price target for 10.00 expecting SEER to rise to within 12 months (a possible 340.53% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Seer (NASDAQ: SEER) is $2.27 last updated Today at September 21, 2023 at 7:35 PM UTC.
There is no dividend information for Seer.
Seer’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Seer.
Seer is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Seer Stock (NASDAQ: SEER) stock price, news, charts, stock research, profile.
Open2.330 | Close- |
Vol / Avg.181.887K / 269.303K | Mkt Cap145.144M |
Day Range2.250 - 2.350 | 52 Wk Range2.320 - 8.780 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 5.070M | 4.008M | -1.062M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-21 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 11.00 | 10.00 |
2023-01-04 | B of A Securities | Derik De Bruin | Downgrades | NeutralUnderperform | Lowers | 9.00 | 6.50 |
2022-11-10 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 14.00 | 11.00 |
2022-08-11 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 19.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SEER | Seer | -3.4% | 145.1M |
HBIO | Harvard Bioscience | 1.71% | 178M |
CDXS | Codexis | -5% | 112.7M |
BLFS | BioLife Solns | -0.08% | 551.9M |
SLGC | SomaLogic | -1.75% | 423.2M |
You can purchase shares of Seer (NASDAQ: SEER) through any online brokerage.
Other companies in Seer’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), SomaLogic (NASDAQ:SLGC) and ChromaDex (NASDAQ:CDXC).
The latest price target for Seer (NASDAQ: SEER) was reported by Morgan Stanley on Tuesday, February 21, 2023. The analyst firm set a price target for 10.00 expecting SEER to rise to within 12 months (a possible 340.53% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Seer (NASDAQ: SEER) is $2.27 last updated Today at September 21, 2023 at 7:35 PM UTC.
There is no dividend information for Seer.
Seer’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Seer.
Seer is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Seer Stock (NASDAQ: SEER) stock price, news, charts, stock research, profile.
Open2.330 | Close- |
Vol / Avg.181.887K / 269.303K | Mkt Cap145.144M |
Day Range2.250 - 2.350 | 52 Wk Range2.320 - 8.780 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 5.070M | 4.008M | -1.062M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-21 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 11.00 | 10.00 |
2023-01-04 | B of A Securities | Derik De Bruin | Downgrades | NeutralUnderperform | Lowers | 9.00 | 6.50 |
2022-11-10 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 14.00 | 11.00 |
2022-08-11 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 19.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SEER | Seer | -3.4% | 145.1M |
HBIO | Harvard Bioscience | 1.71% | 178M |
CDXS | Codexis | -5% | 112.7M |
BLFS | BioLife Solns | -0.08% | 551.9M |
SLGC | SomaLogic | -1.75% | 423.2M |
You can purchase shares of Seer (NASDAQ: SEER) through any online brokerage.
Other companies in Seer’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), SomaLogic (NASDAQ:SLGC) and ChromaDex (NASDAQ:CDXC).
The latest price target for Seer (NASDAQ: SEER) was reported by Morgan Stanley on Tuesday, February 21, 2023. The analyst firm set a price target for 10.00 expecting SEER to rise to within 12 months (a possible 340.53% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Seer (NASDAQ: SEER) is $2.27 last updated Today at September 21, 2023 at 7:35 PM UTC.
There is no dividend information for Seer.
Seer’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Seer.
Seer is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Seer Stock (NASDAQ: SEER) stock price, news, charts, stock research, profile.
Open2.330 | Close- |
Vol / Avg.181.887K / 269.303K | Mkt Cap145.144M |
Day Range2.250 - 2.350 | 52 Wk Range2.320 - 8.780 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 5.070M | 4.008M | -1.062M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-21 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 11.00 | 10.00 |
2023-01-04 | B of A Securities | Derik De Bruin | Downgrades | NeutralUnderperform | Lowers | 9.00 | 6.50 |
2022-11-10 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 14.00 | 11.00 |
2022-08-11 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 19.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SEER | Seer | -3.4% | 145.1M |
HBIO | Harvard Bioscience | 1.71% | 178M |
CDXS | Codexis | -5% | 112.7M |
BLFS | BioLife Solns | -0.08% | 551.9M |
SLGC | SomaLogic | -1.75% | 423.2M |
You can purchase shares of Seer (NASDAQ: SEER) through any online brokerage.
Other companies in Seer’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), SomaLogic (NASDAQ:SLGC) and ChromaDex (NASDAQ:CDXC).
The latest price target for Seer (NASDAQ: SEER) was reported by Morgan Stanley on Tuesday, February 21, 2023. The analyst firm set a price target for 10.00 expecting SEER to rise to within 12 months (a possible 340.53% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Seer (NASDAQ: SEER) is $2.27 last updated Today at September 21, 2023 at 7:35 PM UTC.
There is no dividend information for Seer.
Seer’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Seer.
Seer is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Seer Stock (NASDAQ: SEER) stock price, news, charts, stock research, profile.
Open2.330 | Close- |
Vol / Avg.181.887K / 269.303K | Mkt Cap145.144M |
Day Range2.250 - 2.350 | 52 Wk Range2.320 - 8.780 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.390 | -0.370 | 0.0200 | ||||
REV | 5.070M | 4.008M | -1.062M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-21 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 11.00 | 10.00 |
2023-01-04 | B of A Securities | Derik De Bruin | Downgrades | NeutralUnderperform | Lowers | 9.00 | 6.50 |
2022-11-10 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 14.00 | 11.00 |
2022-08-11 | Morgan Stanley | Tejas Savant | Maintains | Equal-Weight | Lowers | 19.00 | 14.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SEER | Seer | -3.4% | 145.1M |
HBIO | Harvard Bioscience | 1.71% | 178M |
CDXS | Codexis | -5% | 112.7M |
BLFS | BioLife Solns | -0.08% | 551.9M |
SLGC | SomaLogic | -1.75% | 423.2M |
You can purchase shares of Seer (NASDAQ: SEER) through any online brokerage.
Other companies in Seer’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), SomaLogic (NASDAQ:SLGC) and ChromaDex (NASDAQ:CDXC).
The latest price target for Seer (NASDAQ: SEER) was reported by Morgan Stanley on Tuesday, February 21, 2023. The analyst firm set a price target for 10.00 expecting SEER to rise to within 12 months (a possible 340.53% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Seer (NASDAQ: SEER) is $2.27 last updated Today at September 21, 2023 at 7:35 PM UTC.
There is no dividend information for Seer.
Seer’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
There is no upcoming split for Seer.
Seer is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.